Learning objectives: To learn about the preclinical stage of Alzheimer’s disease and risk of cognitive decline.
To evaluate imaging and biomarker detection of early Alzheimer’s disease.
Tuesday, November 10, 2020 - 12:00pm to 1:00pm
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Reisa A. Sperling, MD